Trial intelligence / Profile preview

Esmolol or magnesium infusion during laparoscopic cholecystectomy and postoperative recovery quality

ChiCTR2100041755Phase 4Recruiting

Sponsor
Beijing Chaoyang Hospital
Start
Jan 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esmolol and magnesium sulfate in cholecystitis (3 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: QoR-15 score. Started Jan 2021; status: recruiting.

02

Drugs

esmololmagnesium sulfate
03

Conditions

cholecystitis

Beyond the preview

Go deeper on ChiCTR2100041755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100041755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call